Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue? - Wikidata - wikimedia - TriplyDB

Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?

Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?

http://www.wikidata.org/entity/Q55261242

about

Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?

http://www.wikidata.org/entity/Q55261242

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?

@en

Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?

@nl

type

label

Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?

@en

Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?

@nl

prefLabel

Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?

@en

Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?

@nl

P1433

Q55261242-7C465746-243C-4D08-8184-E2156BF79679

P1476

Q55261242-5EFDCAE9-42D6-4870-B44F-BA70EF44E7AA

P2093

Q55261242-C655E4F9-A340-432B-BAF1-FFFAF131B939

Q55261242-EC230891-7A36-467D-ABD2-212EB5DBB087

Q55261242-F0F540B0-58F0-402A-BBEE-B60DA351B91E

P2860

Q55261242-1E0C55C5-E25F-46F0-8A8A-43A4C5F61EAA

Q55261242-2C46F371-338D-4A43-B661-B86BFBF0E4BD

Q55261242-3C1041F8-8986-4DDD-AD2C-0440A2B65980

Q55261242-50EB6688-33E9-4EED-B12B-2FF9553BD18B

Q55261242-5C8DB360-CC79-4DA1-9EA6-679A89E2F577

Q55261242-66E9BF9E-975D-4242-BEDC-E6442192AC87

Q55261242-716ABBFE-F269-4635-A9D6-FF60765BE683

Q55261242-88FE46F0-0658-4C06-A029-165D67186856

Q55261242-927BD7B0-5B94-4DDB-8985-4B78CEBE3A28

Q55261242-94AFFB2F-BAFA-4F1D-BAEE-E85D7E69A195

P304

Q55261242-81B822F0-2D6F-45D1-ACCA-71625F62F6B3

P31

Q55261242-F33DB7BC-0C78-4A4A-8593-47D506F11692

P356

Q55261242-A11CD45C-C376-4550-8929-07A79624D6CF

P433

Q55261242-FD8C1DE2-96CF-4E4D-8075-BE606CF21662

P478

Q55261242-2B2FCBF7-D8E1-414B-ABED-5F01BE2C3DB0

P577

Q55261242-C95913A3-DBD7-404C-AB81-D7149ACEE23D

P932

Q55261242-82B59F8A-8DE9-4AFC-9925-9BE8CE6D20B8

P356

8755122515617200

P1433

Journal of Pharmacy Technology

P1476

Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?

@en

P2093

Molly G. Minze

http://www.w3.org/2001/XMLSchema#string

Ronald G. Hall

http://www.w3.org/2001/XMLSchema#string

Yu-Yu Kwee

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients

Evaluating the safety and efficacy of BMI-based preoperative administration of low-molecular-weight heparin in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery.

Low-molecular-weight heparins.

Prevention of venous thromboembolism in obesity.

Attaching a spin to a protein -- site-directed spin labeling in structural biology.

Prospective study of BMI and the risk of pulmonary embolism in women.

Role of adipose tissue in haemostasis, coagulation and fibrinolysis.

Venous thromboembolism prophylaxis in the medical patient: controversies and perspectives.

P304

75-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/8755122515617200

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P932

5998535

http://www.w3.org/2001/XMLSchema#string